Search
for
Sort by
Research 151–180 of 343
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Gut–ovary axis and multiomic insights into PCOS in a DHEA-induced rat model
- Plant-based approaches in the management of polycystic ovary syndrome: A review
- Amla: An ancient medicinal plant with wide-ranging properties
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Farmácia Boa Hora - Porto
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence‐Based Interventions
- A Complex Clinical Situation in Polycystic Ovary Syndrome: HAIR‐AN Syndrome ‘‘Case Report’’
- Quercetin and polycystic ovary syndrome
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Enhancing Skin Anti-Aging through Healthy Lifestyle Factors
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications
- Teneligliptin-induced hair loss: A case report
- Exploring Hirsutism: Epidemiology, Associated Endocrinal Abnormalities, and Societal Challenges in GCC—A Narrative Review
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique